TREATMENT OF OSTEOPOROSIS USING GROWTH HORMONE RELEASE FACTOR (GRF) IN COMBINATION WITH PARATHYROID HORMONE (PTH).

摘要

A METHOD FOR THE TREATMENT OF OSTEOPOROSIS, ESPECIALLY POST-MENOPAUSIC OSTEOPOROSIS, WHICH CONSIST OF ADMINISTERING A PATIENT, PERIODICALLY BUT ONGOING, THE GROWTH HORMONE RELEASE FACTOR, GRF (1-44) -NH2 OR A BIOLOGICALLY ACTIVE ANALOG OF THE SAME AND ADMINISTER AT THE SAME TIME A PARATHYROID HORMONE, PTH (1-34) -NH2 AND CONTINUE WITH THE ADMINISTRATION UNTIL INCREASING THE BONE MASS AND THE CALCIUM BALANCE OF THE PATIENT TURN POSITIVE AND INDIUM MINERAL IN THE SKELETON.